Literature DB >> 17143927

Antiproliferative effect of furanocoumarins from the root of Angelica dahurica on cultured human tumor cell lines.

Young-Kyoon Kim1, Young Sup Kim, Shi Yong Ryu.   

Abstract

A bioassay-guided fractionation of the root extract of Angelica dahurica (Umbelliferae) led to the isolation of six furanocoumarins as active ingredients responsible for the antitumoral property. The hexane soluble part of the extract demonstrated a significant inhibition on the proliferation of cultured human tumor cells such as A549 (non small cell lung), SK-OV-3 (ovary), SK-MEL-2 (melanoma), XF498 (central nervous system) and HCT-15 (colon) in vitro, whereas the remaining water soluble part exhibited poor inhibition. Intensive investigation of the hexane soluble part of the extract yielded six furanocoumarins, i.e. isoimperatorin, cnidicin, imperatorin, oxypeucedanin, byakangelicol, oxypeucedanin hydrate, all of which exhibited a significant inhibition on cell proliferation in a dose-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17143927     DOI: 10.1002/ptr.2043

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  23 in total

1.  Effects of isoimperatorin on proliferation and apoptosis of human gastric carcinoma cells.

Authors:  Hai-Bo Yang; Hui-Ru Gao; Yuan-Jing Ren; Fei-Xiang Fang; Hong-Tao Tian; Zhen-Jiang Gao; Wei Song; Shao-Min Huang; An-Fang Zhao
Journal:  Oncol Lett       Date:  2018-03-20       Impact factor: 2.967

2.  Effects of drying methods on contents of bioactive compounds and antioxidant activities of Angelica dahurica.

Authors:  Wei-Hong Liang; Tung-Wu Chang; Yuh-Chyang Charng
Journal:  Food Sci Biotechnol       Date:  2018-03-26       Impact factor: 2.391

3.  Inhibition of melatonin metabolism in humans induced by chemical components from herbs and effective prediction of this risk using a computational model.

Authors:  Chao Wang; Xiaokui Huo; Xiangge Tian; Min Xu; Peipei Dong; Zhilin Luan; Xiaobo Wang; Baojing Zhang; Bo Zhang; Shanshan Huang; Sa Deng; Xiaochi Ma
Journal:  Br J Pharmacol       Date:  2016-10-10       Impact factor: 8.739

Review 4.  Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment.

Authors:  Jing Zhang; Xiang Li; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2020-05-28       Impact factor: 15.470

5.  Isoimperatorin induces apoptosis of the SGC-7901 human gastric cancer cell line via the mitochondria-mediated pathway.

Authors:  Kehui Tong; Chang Xin; Wenzhong Chen
Journal:  Oncol Lett       Date:  2016-11-15       Impact factor: 2.967

6.  Imperatorin is responsible for the vasodilatation activity of Angelica Dahurica var. Formosana regulated by nitric oxide in an endothelium-dependent manner.

Authors:  Hong Nie; Lan-zhen Meng; Jiu-yao Zhou; Xiao-feng Fan; Yong Luo-; Guang-wen Zhang
Journal:  Chin J Integr Med       Date:  2010-01-18       Impact factor: 1.978

7.  Single oral dose pharmacokinetics of decursin and decursinol angelate in healthy adult men and women.

Authors:  Jinhui Zhang; Li Li; Thomas W Hale; Wayne Chee; Chengguo Xing; Cheng Jiang; Junxuan Lü
Journal:  PLoS One       Date:  2015-02-19       Impact factor: 3.240

8.  Combined treatment with quercetin and imperatorin as a potent strategy for killing HeLa and Hep-2 cells.

Authors:  Dorota Bądziul; Joanna Jakubowicz-Gil; Roman Paduch; Kazimierz Głowniak; Antoni Gawron
Journal:  Mol Cell Biochem       Date:  2014-03-30       Impact factor: 3.396

Review 9.  Imperatorin-pharmacological meaning and analytical clues: profound investigation.

Authors:  Ewelina Kozioł; Krystyna Skalicka-Woźniak
Journal:  Phytochem Rev       Date:  2016-02-20       Impact factor: 5.374

10.  Investigation of the mechanisms of Angelica dahurica root extract-induced vasorelaxation in isolated rat aortic rings.

Authors:  Kyungjin Lee; Min Sik Shin; Inhye Ham; Ho-Young Choi
Journal:  BMC Complement Altern Med       Date:  2015-10-31       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.